Management of non-resectable (stage III) breast cancer.
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage; D011832:Radiation Injuries; D012075:Remission, Spontaneous; D012867:Skin / Q000187:drug effects / Q000528:radiation effects; D013997:Time Factors
D000970:Antineoplastic Agents; D003520:Cyclophosphamide; D005472:Fluorouracil; D011241:Prednisone